Subscribe To Our Free Newsletter |
Zydus Life declines after US FDA concludes manufacturing facility inspection with 10 observations
Zydus Lifesciences fell 2.26% to Rs 937.90 after the company informed that the US FDA inspection held at its Gujarat-based injectable manufacturing site had closed with 10 observations.